Searched over 200M research papers
10 papers analyzed
These studies suggest that improving red blood cells can be achieved through genetic targeting (SH2B3 gene), synbiotics (Lactobacillus gasseri and inulin), vitamin supplementation (C and E), specific medications (dipyridamole and aspirin), advanced dialysis membranes, and exercise programs.
20 papers analyzed
Recent studies have shown that genetic manipulation can significantly improve red blood cell (RBC) production from stem cells. Specifically, the SH2B3 gene, which encodes a negative regulator of cytokine signaling, has been identified as a key target. Loss-of-function variants in SH2B3 naturally increase RBC counts in vivo. By using CRISPR/Cas9 genome editing to inactivate SH2B3 in human pluripotent stem cells, researchers have achieved enhanced erythroid cell expansion and improved RBC yield and maturation in vitro.
A study on hypercholesterolemic subjects demonstrated that a synbiotic product containing Lactobacillus gasseri and inulin can improve the shape and function of RBCs. Over a 12-week period, supplementation with this synbiotic reduced the cholesterol:phospholipids ratio in RBC membranes and increased membrane fluidity, which is indicative of healthier and more functional RBCs.
Vitamin C supplementation has been shown to elevate red blood cell glutathione levels, which enhances the antioxidant capacity of blood. In a controlled study, a daily intake of 500 mg of vitamin C increased RBC glutathione by nearly 50%, thereby improving the overall antioxidant protection of the blood.
The combination of dipyridamole and aspirin has been found to improve RBC deformability, which is crucial for efficient blood flow and oxygen delivery. Treatment with these drugs prevented the increased stiffness of RBCs under flow conditions and significantly enhanced their deformability.
In patients undergoing hemodialysis, the type of dialysis membrane used can impact RBC function. Cellulose acetate membranes have been shown to improve osmotic fragility and reduce oxidative stress markers in RBCs compared to traditional cuprophan membranes. Additionally, vitamin E-bonded hemodialyzers not only reduce oxidative stress but also improve RBC viscosity and deformability, which can help in managing atherosclerosis and reducing the need for erythropoietin in treating anemia.
A 12-week program combining resistance and aerobic exercise has been shown to improve RBC hemorheological function in obese older men. This type of exercise regimen enhances RBC deformability and reduces aggregation, which are critical for maintaining efficient blood flow and oxygen delivery during physical activity.
Regular exercise, particularly endurance training, can lead to a decrease in hematocrit due to increased plasma volume. However, this is not indicative of anemia but rather an adaptation that results in a younger population of RBCs with improved oxygen release and deformability, enhancing overall oxygen supply during exercise.
Improving red blood cells can be approached through various methods, including genetic manipulation, dietary supplements, pharmacological treatments, specialized hemodialysis membranes, and regular exercise. Each of these strategies offers unique benefits that can enhance RBC function, improve oxygen delivery, and support overall cardiovascular health.
Most relevant research papers on this topic